Speeches & presentations
Search through our archive of speeches and presentations from conferences and events.
Moncef Slaoui, Chairman of Research & Development and Patrick Vallance, President, Pharmaceuticals R&D, presented a live webcast - Capital Allocation in R&D and a DPU Deep Dive.
PharmEHR Summit, Philadelphia
Deirdre Connelly, President, North America Pharmaceuticals, gave a speech at PharmEHR Summit in Philadelphia about how GSK sees healthcare evolving and how electronic health records fit into that shifting landscape.
Annual JP Morgan Healthcare Conference
Simon Dingemans, Chief Financial Officer, gave a presentation at the 30th Annual JP Morgan Healthcare Conference in San Francisco. Simon provided an overview of the progress being made in implementing GSK’s strategy.
Core Earnings Reporting
Simon Dingemans, Chief Financial Officer discusses the methodology GSK will use for its core earnings reporting to begin with effect from Q1 2012.
Credit Suisse Healthcare Conference, Hong Kong
Abbas Hussain, President, Emerging Markets & Asia Pacific gave a presentation at the Credit Suisse Asia Healthcare Conference in Hong Kong. Abbas provided an overview of GSK's emerging markets strategy.
Bernstein Conference, New York
Adrian Rawcliffe, SVP Finance North American Pharmaceuticals, presented at the Bernstein Pharma Conference: “Pharmaceutical R&D Productivity: Diagnosing the Problem & Searching for Solutions” in New York City. The conference was attended by over 100 investors. Ad discussed GSK’s R&D Strategy and its Focus on Return on Investment.
Citi’s Seminar in London on Vaccines in Emerging Markets
Martin Andrews, SVP – Global Vaccines Centre of Excellence, GSK Biologicals, gave a presentation on GSK’s vaccines business at Citi’s Seminar in London on Vaccines in Emerging Markets.
Andrew Witty presents to the US State Department
GSK CEO Andrew Witty presented at the United States Department of State symposium, “The Role of Innovation in Addressing Global Health”. In his address, which was convened to discuss advances and ways of working together to overcome diseases of the developing world, Andrew expanded upon GlaxoSmithKline’s commitments in this area.
Presentation to investors
Abbas Hussain, President, Emerging Markets, gave a presentation to a small group of investors, where he provided an overview of GSK's emerging markets strategy.
Cowen and Company 31st Annual Health Care Conference
Patrick Vallance, SVP – Medicines Discovery and Development, gave a presentation at the Cowen and Company 31st Annual Health Care Conference in Boston. Patrick provided an overview of GSK’s R&D Strategy and its Focus on Return on Investment.
CED Biotech/Life Science Conference
Deirdre Connelly, President, North American Pharmaceuticals, addressed the CED Biotech/Life Science Conference in Raleigh, Durham, on 21 February 2011.
The Economist Pharma Summit
David Redfern, GSK Chief Strategy Officer, was one of the two keynote speakers at The Economist Pharma Summit Reinventing Pharma for a New Generation on 10 February 2011 in London. He outlined GSK’s strategic priorities, our innovative approach to pricing and the value of our late stage pipeline coupled with our ongoing efforts to drive the effectiveness of R&D.
CBI 8th Annual Pharmaceutical Compliance Conference
Deirdre Connelly, President, North American Pharmaceuticals, addressed the 8th annual Center for Business Intelligence (CBI) pharmaceutical compliance conference on 24 January. Deirdre spoke about what the pharmaceutical industry must do to build trust.
JP Morgan Healthcare Conference
David Redfern, Chief Strategy Officer at GlaxoSmithKline, gave a presentation at the 29th Annual JP Morgan Healthcare Conference in San Francisco. David provided an overview of the progress being made in implementing GSK’s strategy.
CEO Andrew Witty discusses R&D and drug discovery on BBC Radio 4
CEO Andrew Witty discusses R&D and drug discovery on BBC Radio 4.
Eddie Gray, President GSK Pharma Europe, speaks at FT pharmaceutical conference
The 27th annual FT Global Pharmaceutical & Biotechnology Conference took place in London on 1–2 December 2010. The event brought together thought-leaders from the pharmaceutical industry, patient groups, regulators, health technology assessment (HTA) groups to share insights and discuss the future for healthcare and the role of the pharmaceutical industry.
CLSA China Conference
Mark Reilly, GM, Pharmaceuticals China & Hong Kong, gave a presentation at the CLSA China Conference on December 1 in New York City. Mark gave an update on GSK’s strategy and progress in its pharmaceuticals business in China.
CEO Andrew Witty featured in The World in 2011
In The World in 2011, published in November 2010 by The Economist, Andrew Witty, CEO of GlaxoSmithKline, calls on the pharmaceutical industry to do more with less—and still be innovative.
Mind the Medicine Gap
In this Open University programme on global access to medicines, Jon Pender of GlaxoSmithKline discusses the importance of intellectual property and why it is a critical mechanism to allow companies to generate funds for reinvestment to help create the medicines of the future.The programme also discusses how pharmaceutical companies can help to tackle neglected tropical diseases and improve access to medicines in developing nations.
The audio and transcript files are provided courtesy of The Open University.
Credit Suisse Healthcare Conference
Andrew Witty, Chief Executive Officer, gave a presentation at the 2010 Annual Credit Suisse Health Care Conference in Phoenix, AZ. The presentation was attended by over 100 institutional investors and portfolio managers. Andrew provided an overview of the progress being made in implementing the company's strategy.
Find out more
Discover our latest financial performance announcement and search for historical quarterly results materials